Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer

Anticancer Research

Volumn 28, Issue 2 B, 2008, Pages 1133-1138

  Dahlstrand, Hanna ^a   Näsman, Anders ^a   Romanitan, Mircea ^a   Lindquist, David ^a   Ramqvist, Torbjörn ^a   Dalianis, Tina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Head and neck cancer; HPV; Review; Tonsillar cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; PROTEIN E6; PROTEIN E7; WART VIRUS VACCINE;

CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; COMPARATIVE STUDY; DNA SEQUENCE; GENE EXPRESSION; GENOMICS; HUMAN; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TONSIL CANCER; VACCINATION; VERRUCA VULGARIS; VIRUS LOAD; WART VIRUS;

HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TONSILLAR NEOPLASMS;

EID: 42549161808     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM and Jansen KU: A controlled trial of human papillomvavirus type 16 vaccine. N Engl J Med 347: 1645-1651, 2002.
2. Lehtinen M, Malm C, Apter D, Heikkilä R, Heino P, Rimpilä K, Ziliacus R and Paavonen J: Preventive vaccines against papillomavirus and cervical cancer will soon enter routine practice. Läkartidningen 100: 3408-3412, 2003.
3. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skieldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenzy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sinas HL, Saah AJ and Barr E: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6(5): 271-278, 2005.
4. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO and Dubin G: HPV Patricia Study Group. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369(9580): 2161-2170, 2007.
5. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA and Dubin G: HPV study group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367(9518): 1247-1255, 2006.
6. zur Hausen H: Papillomaviruses in human cancers. Proc Assoc Am Physicians 111: 581-587, 1999.
7. de Villiers EM: Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allografts recipients. Int J Cancer 73: 356-361, 1997.
8. Snijders PJF, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB and Walboomers JM: Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral aetiology. Int J Cancer 51: 845-850, 1992.
9. Snijders PJF, Scholes AGM, Hart A, Jones AS, Vaughan ED, Woolgar JA, Meijer CJLM, Walboomers JMM and Field JK: Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. Int J Cancer 66: 464-469, 1996.
10. Mellin H, Friesland S, Lewensohn R, Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in tonsillar cancer; clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300-304, 2000.
11. Gillison ML, Koch WM and Shah KV: Human papillomaviruses-associated head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol 11: 191-199, 1999.
12. Syrjänen S: Human papillomaviruses in head and neck carcinomas. N Engl J Med 356(19): 1993-1995, 2007.
13. Nathanson A, Lewin F, Lind M, Lundgren J and Strander H: Huvudhals och esofaguscancer, Onkologisk Centrum Stockholm-Gotland, 1999.
14. Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J, Dalianis T, Ye W and Munck-Wikland E: The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127: 988-992, 2007.
15. Syrjanen S: HPV infections and tonsillar carcinoma. J Clin Pathol 57(5): 449-455, 2004.
16. Frisch M, Hjalgrim H, Jaeger AB and Biggar RJ: Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 11(6): 489-495, 2000.
17. Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, Lindholm J, Ramqvist T, Ye W, Munck-Wikland E and Dalianis T: Human papillomavirus is a prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Molecular Oncol 1: 350-355, 2007.
18. Shah K and Howley PM: Papillomaviruses. In: Virology, 2nd Edition. Fields BN, Knipe DM, Chanoch RM, Hirsch MS, Melnick JL, Monath TP and Roizman B (eds.). pp. 1651-1676, 1990.
19. Schneider A and Koutsky L: Natural history and epidemiological features of genital HPV infection. The epidemiology of cervical cancer and human papillomavirus. Munoz N, Bosch FX, Shah KV and Meheus A (eds.). Lyon IARC Scientific Publications 119: 25-52, 1992.
20. van den Brule A, Snijders P, Meijer C and Walboomers J: PCR-based detection of genital HPV genotypes: an update and future perspectives. Papillomavirus Report 4: 95-99, 1993.
21. Higgins G, Uzelin D, Phillips G, Pieterse S and Burell C: Differing characteristics of human papillomavirus RNA-positive and RNA-negative anal carcinomas. Cancer 68: 561-567, 1991.
22. Heino P, Eklund C, Fredriksson-Shanazarian V, Goldman S, Serieller J and Dillner J: Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst 87: 437-440, 1995.
23. Snijders, PJF, van den Brule AJC, Meijer CJ and Walboomers JM: Papillomaviruses and cancer of the upper digestive and respiratory tracts. Curr Top Microbiol Immunol 186: 177-198, 1994.
24. Syrjanen SM and Syrjanen KJ: New concepts on the role of human papillomavirus in cell regulation. Ann Med 31: 175-187, 1999.
25. Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissman L, Lowy DR and Schiller JT: Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 67: 6929-6936, 1993.
26. Paz IB, Cook N, Odom-Maryon T, Xie Y and Wilczynski SP: Human papillomavirus (HPV) in head and neck cancer: an association of HPV with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79: 595-604, 1997.
27. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M and Dalianis T: Human papillomavirus type 16 is episomal and a high viral load is correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152-158, 2002.
28. Dahlstrand H and Dalianis T: Presence and Influence of human papillomavirus in tonsillar cancer. Adv Cancer Res 93: 59-89, 2005.
29. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren L, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T and Munck-Wikland E: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119: 2620-2623, 2006.
30. de Roda Husman AM, Walboomers JM, van der Brule AJ, Meijer CJ and Sneijders PJ: The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J General Virol 76: 1057-1062, 1995.
31. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, Jebbink MF and Smits HL: Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42: 265-279, 1993.
32. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ and Snijders PJ: GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40(3): 779-787, 2002.
33. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M and Quint W: Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37(8): 2508-2517, 1999.
34. Hagmar B, Johansson B, Kalantari M, Petersson Z, Skyldberg B and Walaas L: The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother 9: 113-117, 1992.
35. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Gabriel R, Quereux C and Birembaut P: Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 80(9): 1306-1311, 1999.
36. Hesselink AT, van den Brule AJ, Brink AA, Berkhof J, van Kemenade FJ, Verheijen RH and Snijders PJ: Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples Cancer 102(1): 11-18, 2004.
37. DÏSouza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, Minkopp HL, Anastos K, Palefsky JM and Gillison ML: Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 121(1): 143-150, 2007.
38. Gillison ML, Koch WM, Caoibe RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720, 2000.
39. Friesland S, Mellin H, Dalianis T, Munck-Wikland E and Lewensohn R: Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma - relation to radiotherapy response and survival. Anticancer Res 21: 529-534, 2001.
40. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Hadad K, Björnestå hl L, Lindholm J, Munck-Wikland E, Auer G, Ried T and Dalianis T: Comparative genomic hybridization (CGH) analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus (HPV) positive and negative tumors. Int J Cancer 107: 244-249, 2003.
41. Reithdorf S, Friedrich RE, Ostwald C, Barten M, Gogacz P, Gundlach KK, Schlechte H, Bregenzer T, Reithdorf L and Loning T: p3 mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 26: 315-321, 1997.
42. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Heibig M, Dietz A, Weidauer H and Bosch FX: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinoma lacking retinoblastoma cell cycle control. Cancer Res 58: 5-13, 1998.
43. Friesland S, Fernberg JO, Lundell G, Munck-Wikland E, Strander H and Lewensohn R: Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: A retrospective analysis of the Radiumhemmet data, 1980-1995. Int Radiat Onc Biol Physics 45: 1259-1266, 1999.
44. INK4a correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 25: 4375-4384, 2005.
45. Mellin H, Friesland S, Auer G, Dalianis T and Munck-Wikland E: Human papillomavirus and DNA ploidy in tonsillar cancer-correlation to prognosis. Anticancer Res 23: 2821-2828, 2003.
46. Rihet S, Lorenzato M and Clavel C: Oncogenic human papillomaviruses and ploidy in cervical lesions. J Clin Pathol 49: 892-896, 1996.
47. Lorenzato M, Clavel C, Masure M, Nou JM, Bouttens D, Evrard G, Bory JP, Maugard B, Quereux C and Birembaut P: DNA image cytometry and human papillomavirus (HPV) detection help to select smears at high risk of high-grade cervical lesions. J Pathol 194: 171-176, 2001.
48. Skyldberg B, Fujioka K, Hellström AC, Sylven L, Moberger B and Auer G: Human papillomavirus infection, centrosome aberration and genetic stability in cervical lesions. Mod Pathol 14: 279-284, 2001.